SCHEMBL6584464

SCHEMBL6584464

ClCc1ccc2ccc(Br)cc2n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.52
HTT P42858 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 2/20 0.46
ALDH1A1 P00352 2/20 0.38
MAPT P10636 2/20 0.38
RXFP1 Q9HBX9 2/20 0.38
LMNA P02545 1/20 0.38
PPARG P37231 1/20 0.38
GFER P55789 1/20 0.38
NCOA2 Q15596 1/20 0.38
NCOA1 Q15788 1/20 0.38
NOS1 P29475 1/20 0.37
METAP2 P50579 1/20 0.37
DYRK1A Q13627 1/20 0.37
PABPC1 P11940 1/20 0.36
CYP2A6 P11509 1/20 0.35
HDAC1 Q13547 3/20 0.35
HDAC2 Q92769 3/20 0.35
KMT2A Q03164 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1599323 0.86 BACE1 (0.53) BACE1HTTCYP1A2CYP2C19ALDH1A1
SCHEMBL10402926 0.82 BACE1 (0.53) BACE1HTTCYP1A2CYP2C19ALDH1A1
SCHEMBL2273496 0.80 BACE1 (0.52) BACE1HTTCYP1A2CYP2C19ALDH1A1
SCHEMBL17179408 0.80 BACE1 (0.52) BACE1HTTCYP1A2CYP2C19ALDH1A1
SCHEMBL25285818 0.80 BACE1 (0.57) BACE1HTTCYP1A2CYP2C19ALDH1A1
SCHEMBL3276372 0.78 NR4A2 (0.47) CYP1A2MAPTLMNAGFERNOS1
SCHEMBL9757427 0.77 MAPT (0.42) HTTALDH1A1MAPTLMNAKMT2A
SCHEMBL14756202 0.77 BACE1 (0.53) BACE1HTTCYP1A2CYP2C19ALDH1A1
SCHEMBL6586916 0.76 KMT2A (0.56) BACE1CYP1A2ALDH1A1MAPTLMNA
SCHEMBL5208223 0.76 PDE10A (0.42) BACE1CYP1A2CYP2A6HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0784052-B1 Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation AVENTIS HOLDINGS INC (US) 2004-09-01 EP disclosed
CN-1054845-C Quinoline compounds NOVARTIS AG (CH) 2000-07-26 CN disclosed
EP-0643045-B1 Quinoline derivatives as leukotriene antagonists NOVARTIS AG (CH) 2000-03-08 EP disclosed
EP-0784052-A1 Quinoline derivatives as antagonists of leukotriene d4, compositions containing the same and processes for their preparation RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1997-07-16 EP disclosed
US-5508408-A LEUKOTRIENE ANTAGONISTS CIBA-GEIGY CORPORATION (US) 1996-04-16 US disclosed
CN-1105991-A Quinoline compounds CIBA GEIGY AG (CH) 1995-08-02 CN disclosed
EP-0643045-A1 Quinoline derivatives as leukoriene antagonists CIBA-GEIGY AG (CH) 1995-03-15 EP disclosed
EP-0434827-A1 QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D 4? RORER INTERNATIONAL (HOLDINGS), INC. (US) 1991-07-03 EP disclosed
WO-1991001123-A2 QUINOLINYL-BENZOPYRAN DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D¿4? RORER INTERNATIONAL (OVERSEAS) INC. (US) 1991-02-07 WO disclosed
US-4977162-A Quinolinyl-chromone derivatives and use for treatment of hypersensitive ailments RORER PHARMACEUTICAL CORPORATION (US) 1990-12-11 US disclosed
US-4920131-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed
EP-0348155-A1 Quinoline derivatives as antagonists of leukotriene D4, compositions containing the same and processes for their preparation RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1989-12-27 EP disclosed